Joel Morganroth
Director/Board Member at ACR Image Metrix
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Edwin J. Thomas | M | 65 |
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | 15 years |
| Paul B. Hays | M | - |
University of Michigan
| 65 years |
| Paul H. Ellenbogen | M | - |
ACR Image Metrix
| - |
| Harvey L. Neiman | M | - |
ACR Image Metrix
| - |
| Michael Otto | M | 75 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | 5 years |
| Bryan R. Wood | M | 78 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | 14 years |
| Donald P. Rosen | M | - |
ACR Image Metrix
| - |
| Patrick J. Maguire | M | 71 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | 3 years |
| Jonathan Lewin | M | - |
ACR Image Metrix
| - |
| Michael E. Lusty | M | 61 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | 13 years |
| Frank Seidman | M | 71 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | 12 years |
| Shawn Farley | M | - |
ACR Image Metrix
| - |
| Carolyn Meltzer | F | - |
ACR Image Metrix
| - |
| Matthew Allen Cromie | M | 58 |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Sampson | M | - |
University of Michigan
| 11 years |
| John R. Kreick | M | 79 |
University of Michigan
| 8 years |
| Andrew J. Fishleder | M | 71 |
University of Michigan
| 4 years |
| Robert Jagunich | M | 76 |
University of Michigan
| 6 years |
| Nicolaos G. Alexopoulos | M | 82 |
University of Michigan
| 4 years |
| Alan J. Goldman | M | 78 |
University of Michigan
| 8 years |
| Robert Laskowski | M | - |
University of Michigan
| 7 years |
| Richard Baton Meyer | M | - |
University of Michigan
| 5 years |
| Roger A. Goldman | M | - |
University of Michigan
| 7 years |
| Thomas J. Fleszar | M | - |
University of Michigan
| 11 years |
| Ronald R. Glancz | M | - |
University of Michigan
| 3 years |
| Robert H. Daskal | M | 82 |
University of Michigan
| 7 years |
| William Jeffery | M | - |
University of Michigan
| 5 years |
| Daniel C. Molhoek | M | 82 |
University of Michigan
| 8 years |
| Edward H. Pappas | M | - |
University of Michigan
| 8 years |
| Richard Crandall | M | 80 |
University of Michigan
| 5 years |
| James Toreson | M | 79 |
University of Michigan
| 5 years |
| Ted Theodore | M | - |
University of Michigan
| 5 years |
| Leslie Goldman | M | 78 |
University of Michigan
| 7 years |
| Allan J. Sweet | M | 76 |
University of Michigan
| 9 years |
| Richard K. Aland | M | 80 |
University of Michigan
| 5 years |
| Randolph H. Fields | M | 82 |
University of Michigan
| 3 years |
| Robert A. Armitage | M | 75 |
University of Michigan
| 3 years |
| Randolph Agley | M | 81 |
University of Michigan
| 2 years |
| Charles M. Vest | M | - |
University of Michigan
| 4 years |
| Michael L. McMillan | M | 80 |
University of Michigan
| 1 years |
| John M. Powers | M | - |
University of Michigan
| 8 years |
| Irwin Deutch | M | - |
University of Michigan
| 7 years |
| George L. Farr | M | 83 |
University of Michigan
| 5 years |
| Charles Newman | M | - |
University of Michigan
| 5 years |
| Ellen Zuckerman | F | - |
University of Michigan
| 4 years |
| Allen P. McKee | M | 82 |
University of Michigan
| - |
| Samuel M. Surloff | M | 70 |
University of Michigan
| 4 years |
| Robert Motto Brown | M | - |
University of Michigan
| 1 years |
| Elliot A. Spoon | M | 73 |
University of Michigan
| 4 years |
| Jeffrey H. Smith | M | - |
University of Michigan
| 3 years |
| Jim E. Daverman | M | - |
University of Michigan
| 4 years |
| Ira J. Jaffe | M | - |
University of Michigan
| - |
| Bruce R. Maxim | M | 70 |
University of Michigan
| 4 years |
| Wolfgang Knapp | M | - |
University of Michigan
| 3 years |
| Christopher Angle | M | 72 |
University of Michigan
| 4 years |
| Rolf G. Hille | M | - |
University of Michigan
| 4 years |
| Bob Heath | M | - |
University of Michigan
| 4 years |
| Gregory Zack | M | - |
University of Michigan
| 4 years |
| Ting Kuo Chen | M | 87 |
University of Michigan
| 3 years |
| Mark A. Vander Laan | M | - |
University of Michigan
| 3 years |
| Robert Irving Kessler | M | 82 |
University of Michigan
| 4 years |
| Richard Rogalski | M | - |
University of Michigan
| 4 years |
| Peter Michael Swift | M | 79 |
University of Michigan
| 5 years |
| Jacob W. Haas | M | 76 |
University of Michigan
| 4 years |
| Michael K. Menerey | M | 72 |
University of Michigan
| 4 years |
| Abdul Aziz Sultan Al Essa | M | - |
University of Michigan
| 3 years |
| William E. Shell | M | 81 |
University of Michigan
| - |
| David E. Politziner | M | - |
University of Michigan
| 2 years |
| Robert Kiah | M | - |
University of Michigan
| 4 years |
| David Pijor | M | 71 |
University of Michigan
| 4 years |
| Robert F. Belden | M | 76 |
University of Michigan
| 4 years |
| Murray J. Feiwell | M | 86 |
University of Michigan
| - |
| Bill H. Younger | M | 74 |
University of Michigan
| 4 years |
| William Parfet | M | 77 |
University of Michigan
| 2 years |
| Mark L. Gordon | M | - |
University of Michigan
| 4 years |
| Douglas R. Schrank | M | 76 |
University of Michigan
| 2 years |
| Richard M. Haddrill | M | 70 |
University of Michigan
| 4 years |
| Rocque E. Lipford | M | 85 |
University of Michigan
| 3 years |
| Daniel Gunsett | M | 75 |
University of Michigan
| 4 years |
| Gregory T. Mutz | M | 78 |
University of Michigan
| 3 years |
| Thomas W. Ostrander | M | 73 |
University of Michigan
| 4 years |
| Bob M. Kock | M | 82 |
University of Michigan
| 1 years |
| Lionel M. Allan | M | - |
University of Michigan
| 4 years |
| Allan J. Reich | M | - |
University of Michigan
| 3 years |
| Thomas G. Morgan | M | - |
University of Michigan
| 3 years |
| Warren J. Schwarzman | M | - |
University of Michigan
| 4 years |
| Norman Allen | M | 72 |
University of Michigan
| 4 years |
| Leslie Murphy | F | 72 |
University of Michigan
| 4 years |
| Robert M. Dell | M | - |
University of Michigan
| 4 years |
| Cecil M. Phillips | M | - |
University of Michigan
| 3 years |
| John S. Huntley | M | 75 |
University of Michigan
| 4 years |
| Kenneth R. Pepperney | M | 77 |
University of Michigan
| 2 years |
| Henry B. Cooney | M | - |
University of Michigan
| 4 years |
| Robert Horwitz | M | - |
University of Michigan
| 4 years |
| Chris Theodore | M | - |
University of Michigan
| 4 years |
| Jeffrey Yaker | M | - |
University of Michigan
| 4 years |
| Robert Heberlein | M | 83 |
University of Michigan
| 3 years |
| Don L. Kohn | M | - |
University of Michigan
| 3 years |
| Thomas N. Gladwin | M | 74 |
University of Michigan
| 2 years |
| Michael Posner | M | 73 |
University of Michigan
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Joel Morganroth
- Personal Network
